Owen A. O’Connor M.D., Ph.D.
Co-Founder and Director, Therasis, Inc.
Dr. Owen A. O’Connor, M.D., Ph.D. serves as Attending Physician in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York City, where Dr. O’Connor serves as the Head of the Laboratory of Experimental Therapeutics for the Lymphoproliferative Malignancies. He serves as an associate professor of medicine and a leader of the Lymphoid Development and Malignancy program at Columbia University Medical Center.
Dr. O’Connor co-founded Therasis, Inc. in 2007.
His research interests focus on the discovery and development of novel small molecules for the treatment of hematologic malignancies. Dr. O’Connor is an internationally recognized leader in the discovery and development of new drugs for the treatment of hematologic malignancies, in particular lymphoma.
To date his laboratory and clinical research efforts have led to the U.S. FDA approval of several drugs for the treatment of lymphoma, including the proteasome inhibitor bortezomib for the treatment of mantle cell lymphoma, the histone deacetylase inhibitor vorinostat for the treatment of cutaneous T-cell lymphoma (CTCL), and most recently pralatrexate, the first drug ever approved for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL).
Dr. O’Connor co-invented and developed pralatrexate at Memorial Sloan-Kettering Cancer Center, which became the first drug ever approved by the FDA for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
He serves as Member of Scientific Advisory Board at Stemline Therapeutics, Inc.
He served as Member of Medical Advisory Board of Cornerstone Pharmaceuticals, Inc.
Dr. O’Connor went on to do a medical internship and residency at the New York Hospital-Cornell University Medical Center. Following his medical residency, he did a fellowship in Medical Oncology at the Memorial Sloan Kettering Cancer Center, and a Fellowship in Clinical Pharmacology at the New York Hospital-Cornell University Medical School. Dr. O’Connor received his B.S. in Biology, magna cum laude, from Manhattan College in 1982, his Ph.D. in Biochemical Toxicology and Chemical Carcinogenesis from NYU School of Medicine, and his M.D. from the University of Medicine & Dentistry of New Jersey-Robert Wood Johnson Medical School in 1994.
# – # – # – # – #
O’Connor, Owen [MC1982]
# – # – # – # – # 2015-Feb-21 @ 12:30